Background: Domain-specialized LLMs
OpenEvidence is the most widely used medical search engine in the U.S., trusted by over 60% of physicians across 10,000+ hospitals and medical centers. OpenEvidence's approach centers on training domain-specialized Large Language Models (LLMs) rather than relying on general-purpose AI.
Key differentiators in their model strategy include:
Trusted data sources only: Models are trained exclusively on peer-reviewed medical literature rather than the open internet or social media to ensure accuracy and avoid low-quality medical information.
Research journal partnerships: OpenEvidence has signed exclusive content agreements with the New England Journal of Medicine (NEJM), the JAMA Network specialty journals, and the National Comprehensive Cancer Network (NCCN) Guidelines.
Medical benchmark leadership: OpenEvidence created the first AI to score above 90% on the United States Medical Licensing Examination (USMLE), which later became the first AI in history to achieve a perfect 100% score.
OpenEvidence owns their AI stack through custom, domain-specific models that present the right information at the right time to doctors. While closed-source models offer strong general capabilities, they impose constraints like non-secure data, high cost per token, reliability and latency issues, and the inability to optimize for domain-specific performance. For a medical AI company embedding intelligence throughout their product, these limitations compounded quickly.
For this effort, OpenEvidence's machine learning team needed infrastructure that could support aggressive training experimentation, especially for highly specialized medical use cases where new information is published daily and rapid iteration is critical.


